Abstract
We studied the cost of follow-up of 472 breast cancer patients without distant metastasis after primary treatment in four different schedules in a randomized trial. The mean follow-up was 4.2 years. The four schedules differed in frequency of follow-up visits (every third or sixth month) and in intensity of diagnostic examinations (routine or on clinical grounds). Neither the frequency of visits nor the intensity of diagnostic examinations had any effect on disease-free or overall survival of patients. The total costs of follow-up, however, were different in the four follow-up schedules and varied between arms per patient from 1050 to 2269€ and per detected recurrence from 4166 to 9149€. Outpatient visits every third month compared to every sixth month and routine examinations in the follow-up of asymptomatic primary breast cancer patients do not improve patient disease-free or overall survival, but increase the costs of follow-up 2.2 times.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cancer Incidence in Finland 2005. Helsinki, Finnish Cancer Registry, 2005
G Macones S Goldie J Peipert (1999) ArticleTitleCost-effectiveness analysis: an introductory guide for clinicians Obstet Gynecol 54 IssueID10 663–672
M Maltoni O Nanni M Naldoni P Serra D Amadori (1998) ArticleTitleEvaluation of cost of home therapy for patients with terminal diseases Curr Opin Oncol 10 302–309 Occurrence Handle9702397
J Coast (2004) ArticleTitleIs economic evaluation in touch with society’s health values? BMJ 329 1233–1236 Occurrence Handle10.1136/bmj.329.7476.1233 Occurrence Handle15550430
T Szucs (1998) ArticleTitleThe growing importance of cost-effectiveness in oncologic practice Curr Opin Oncol 10 279–283 Occurrence Handle9702393
R Kokko M Hakama K Holli (2003) ArticleTitleRole of chest X-ray in diagnosis of the first breast cancer relapse: a randomized trial Breast Cancer Res Treat 81 33–39 Occurrence Handle10.1023/A:1025419114857 Occurrence Handle14531495
TN Chiricos JC Ruckdeschel JP Krischer (2001) ArticleTitleEconomic analysis of cancer treatment costs: another tool for oncology managers J Oncol Manage 10 IssueID3 11–17
A Legorreta R Brooks A Leibowitz L Solin (1996) ArticleTitleCost of breast cancer treatment. a 4-year longitudinal study Arch Intern Med 156 2197–2201 Occurrence Handle10.1001/archinte.156.19.2197 Occurrence Handle8885818
K Holli M Hakama T Hakala (1996) ArticleTitleUse of hospital services by breast cancer patients by stage of disease: implications on the cost of cancer control Breast cancer Res Treat 37 237–241 Occurrence Handle10.1007/BF01806505 Occurrence Handle8825135
R Kokko K Holli M Hakama (2002) ArticleTitleCa 15–3 in the follow-up of localised breast cancer: a prospective study Eur J Cancer 38 1182–1193 Occurrence Handle10.1016/S0959-8049(01)00429-4
M Rosselli Turco ParticleDel D Palli A Cariddi S Ciatto P Pacini V Distante (1994) ArticleTitleIntensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial JAMA 271 1593–1597 Occurrence Handle10.1001/jama.271.20.1593 Occurrence Handle7848404
A Liberati (1995) ArticleTitleThe GIVIO trial on the impact of follow-up care on survival and quality of life in breast cancer patients Ann Oncol 6 41–46
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kokko, R., Hakama, M. & Holli, K. Follow-up Cost of Breast Cancer Patients with Localized Disease After Primary Treatment: a Randomized Trial. Breast Cancer Res Treat 93, 255–260 (2005). https://doi.org/10.1007/s10549-005-5199-2
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-5199-2